Hot off of a $210M Se­ries B, Umo­ja breaks ground in Col­orado on CAR-T site

Boul­der Coun­ty, CO, is get­ting a new man­u­fac­tur­ing fa­cil­i­ty, and it will come from a Seat­tle on­col­o­gy com­pa­ny fo­cused on CAR T-cell im­munother­a­pies.

Umo­ja Bio­phar­ma broke ground on a new fa­cil­i­ty for in vi­vo im­munother­a­pies for sol­id tu­mors and hema­to­log­ic ma­lig­nan­cies, the com­pa­ny an­nounced Mon­day. The site is the com­pa­ny’s next step to­ward bring­ing CAR-T ther­a­pies to can­cer pa­tients. The 146,000-square-foot fa­cil­i­ty will have labs, of­fices and space for lentivi­ral vec­tor pro­duc­tion.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER